| Hang Seng Index | 25.560 HKD | -0.100 | -0.390% | 393.27M | 10.08B | 25.685 (-0.485%) HKD as at 2025/08/20 | | |
| Hang Seng China Enterprises | 91.640 HKD | -0.440 | -0.478% | 67.42M | 6.19B | 92.225 (-0.634%) HKD as at 2025/08/20 | | |
| Hang Seng TECH Index | 5.385 HKD | -0.055 | -1.011% | 884.02M | 4.78B | 5.442 (-1.055%) HKD as at 2025/08/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.395 HKD | -0.105 | -1.909% | 123.68M | 671.60M | 5.503 (-1.961%) HKD as at 2025/08/20 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.578 HKD | +0.032 | +2.070% | 182.88M | 286.69M | 1.548 (+1.918%) HKD as at 2025/08/20 | | |
| Hang Seng TECH Index | 6.990 HKD | -0.070 | -0.992% | 40.24M | 283.67M | 7.059 (-0.982%) HKD as at 2025/08/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.710 HKD | -0.050 | -0.868% | 24.02M | 137.67M | 5.738 (-0.495%) HKD as at 2025/08/20 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.008 HKD | +0.016 | +0.803% | 56.81M | 113.77M | 2.000 (+0.415%) HKD as at 2025/08/20 | | |
| Hang Seng China Enterprises | 10.700 HKD | -0.020 | -0.187% | 8.59M | 91.90M | 10.680 (+0.186%) HKD as at 2025/08/19 | | |
| CSI 300 | 48.340 HKD | +0.240 | +0.499% | 1.87M | 90.48M | 47.412 (+1.957%) HKD as at 2025/08/19 | | |
| FTSE China A50 | 15.410 HKD | +0.130 | +0.851% | 5.43M | 83.65M | 15.106 (+2.013%) HKD as at 2025/08/19 | | |
| Hang Seng TECH Index | 5.470 HKD | -0.060 | -1.085% | 15.09M | 82.90M | 5.528 (-1.042%) HKD as at 2025/08/19 | | |
| Hang Seng TECH Index | 11.550 HKD | -0.100 | -0.858% | 6.23M | 72.29M | 11.679 (-1.102%) HKD as at 2025/08/19 | | |
| FTSE China A50 | 14.340 HKD | +0.090 | +0.632% | 2.77M | 39.71M | 14.234 (+0.743%) HKD as at 2025/08/20 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.270 HKD | +0.170 | +0.994% | 2.26M | 38.66M | 16.932 (+1.998%) HKD as at 2025/08/20 | | |
| HSI ESG Enhanced Index (net total return index) | 53.960 HKD | -0.140 | -0.259% | 618.89K | 33.40M | 54.077 (-0.215%) HKD as at 2025/08/20 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.250 HKD | +0.250 | +2.500% | 1.88M | 19.41M | 10.014 (+2.356%) HKD as at 2025/08/20 | | |
| London Gold Fixing Price | 2,402.000 HKD | +9.000 | +0.376% | 7.27K | 17.46M | N/A | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.836 HKD | +0.026 | +0.682% | 4.45M | 17.07M | 3.782 (+1.417%) HKD as at 2025/08/19 | | |
| Hang Seng High Dividend Yield | 30.420 HKD | +0.080 | +0.264% | 559.10K | 17.04M | 30.126 (+0.975%) HKD as at 2025/08/19 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 16.650 HKD | +0.130 | +0.787% | 881.10K | 14.71M | 16.401 (+1.521%) HKD as at 2025/08/19 | | |
| Hang Seng Index | 23.500 CNY | -0.120 | -0.508% | 506.00K | 11.94M | 23.613 (-0.477%) CNY as at 2025/08/20 | | |
| Short-term deposits and high quality money market investments | 9,352.000 HKD | +3.000 | +0.032% | 1.15K | 10.75M | 9,348.592 (+0.036%) HKD as at 2025/08/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.300 HKD | +0.020 | +0.467% | 1.94M | 8.37M | 4.261 (+0.906%) HKD as at 2025/08/20 | | |
| SSE Science and Technology Innovation Board 50 Index | 10.580 HKD | -0.030 | -0.283% | 720.10K | 7.70M | 10.556 (+0.225%) HKD as at 2025/08/20 | | |
| FTSE US Treasury 20+ Years Index | 67.680 HKD | +0.100 | +0.148% | 110.55K | 7.48M | 67.525 (+0.229%) HKD as at 2025/08/19 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 5.370 HKD | -0.095 | -1.738% | 1.34M | 7.30M | 5.427 (-1.045%) HKD as at 2025/08/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 28.240 HKD | -0.180 | -0.633% | 244.90K | 6.90M | 28.521 (-0.986%) HKD as at 2025/08/19 | | |
| FactSet China Semiconductor Index (net total return) | 47.000 HKD | +0.080 | +0.171% | 127.52K | 6.05M | 45.127 (+4.151%) HKD as at 2025/08/19 | | |
| MSCI China A 50 Connect Index (net total return index) | 5.845 HKD | +0.025 | +0.430% | 928.60K | 5.43M | 5.810 (+0.602%) HKD as at 2025/08/20 | | |